Article info
PDFOriginal article
Heart failure and cardiomyopathy
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
- Dr K M Goode, Department of Cardiology, Division of Cardiovascular & Respiratory Studies, Postgraduate Medical Institute, 1st Floor, Medical Research Building, Entrance 2, Castle Hill Hospital, Castle Road, Kingston-upon-Hull HU16 5JQ, UK; kevin.goode{at}hey.nhs.uk
Citation
Elevated glycated haemoglobin is a strong predictor of mortality in patients with left ventricular systolic dysfunction who are not receiving treatment for diabetes mellitus
Publication history
- Accepted January 20, 2009
- First published February 19, 2009.
Online issue publication
October 25, 2017
Article Versions
- Previous version (15 March 2016).
- You are viewing the most recent version of this article.
- latest version (25 October 2017).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group and British Cardiac Society